Figure 1. The patient is unable to stand up because of pain. She is short for her age, and there is bowing in her legs.
Figure 2. Radiographs of the patient's extremities show osteoporosis and severe rickets.
Figure 3. Results of liver needle aspiration biopsy show glycogen accumulation (hematoxylin-eosin, original magnification ×200).
Fanconi-Bickel syndrome is a rare type of glycogen storage disease first described by Fanconi and Bickel in 1949.1 It is an autosomal recessive disease for which an enzymatic defect has not yet been identified. The disease is characterized by the association of a large liver with massive glycogen accumulation and severe renal tubular dysfunction.2 Renal Fanconi syndrome, characterized by urinary loss of phosphate, amino acids, glucose, and bicarbonate, results in severe hypophosphatemic rickets and markedly stunted growth.3
Affected children usually present in the first year of life with failure to thrive. A protuberant abdomen with hepatomegaly and enlarged kidneys are noticeable by age 2 years.4 These children develop severe hypophosphatemic rickets early in life unless they receive oral phosphate supplementation. Orally administering phosphate alone to the extent necessary for correction of hypophosphatemia may heal the florid rickets, but adequate growth is not attained. At adolescence these children have an extremely short stature. After puberty the hepatomegaly may recede although hepatic glycogen concentration remains increased. Some patients have additional muscular involvement.5
Proximal renal tubular dysfunction with glucosuria, phosphaturia, generalized aminoaciduria, bicarbonate wasting, and hypophosphatemia are characteristic findings. Serum alkaline phosphatase levels are increased, and there are radiological findings of rickets. Mild fasting hypoglycemia and hyperlipidemia may be present, but these are not consistent findings. Uric acid levels are low. Liver transaminases and plasma lactate are usually normal. Results of tissue biopsy show marked accumulation of glycogen in the hepatocytes and proximal renal tubular cells.
There is no known enzyme deficiency. All measured hepatic glycolytic enzyme activities are normal. Oral galactose tolerance tests typically show galactose intolerance, suggesting an impairment of galactose metabolism. Defective galactose oxidation can be demonstrated in vitro in fresh minced liver tissue and fibroblasts, despite normal activities of hepatic galactokinase, uridyltransferase, and uridyl di phospho–glucose 4-epimerase in homogenates of frozen liver.6
There is no specific therapy. Symptomatic replacement of water, electrolytes, vitamin D, and phosphate, restriction of galactose intake, and adequate caloric intake may improve growth. Long-term prognosis is not known.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and
Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early
dhildhood mortality and growth failure data and their association with maternal
Thank you for submitting a comment on this article. It will be reviewed by JAMA Pediatrics editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.